Seres Therapeutics Inc (MCRB) — Free Cash Flow Generation Index
Seres Therapeutics Inc (MCRB) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $2.20 Million represents 1% of operating cash flow ($2.21 Million). Explore reinvestment intensity of Seres Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seres Therapeutics Inc Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Seres Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Seres Therapeutics Inc generate cash.
Annual Free Cash Flow Generation for Seres Therapeutics Inc (2016–2025)
Year-by-year Free Cash Flow Generation Index for Seres Therapeutics Inc. Check MCRB cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | $865.00K | $1.12 Million | $252.00K | ▲ +280.0% |
| 2021 | -0.43x | $-2.88 Million | $6.69 Million | $9.57 Million | ▼ -184.3% |
| 2016 | 0.51x | $22.43 Million | $43.92 Million | $21.49 Million | — |